Parafend 9.06 % Oral Suspension

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

유효 성분:

Oxfendazole

제공처:

Norbrook Laboratories (Ireland) Limited

ATC 코드:

QP52AC02

INN (International Name):

Oxfendazole

복용량:

9.06 percent weight/volume

약제 형태:

Oral suspension

처방전 유형:

LM: Licensed Merchant as defined in relevant national legislation

치료 영역:

oxfendazole

승인 상태:

Authorised

승인 날짜:

1994-02-10

제품 특성 요약

Health Products Regulatory Authority
27 February 2019
CRN008WGG
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Parafend 9.06 % Oral Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
Active Substance:
Oxfendazole
9.06 % w/v
Excipients:
Sodium Methyl Parahydroxybenzoate 0.18 % w/v
(preservative)
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Oral suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle and sheep.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Parafend is a broad spectrum anthelmintic for the treatment and
control of mature and developing immature gastro-intestinal
roundworms and lungworms and also tapeworms in cattle and sheep.
Parafend 9.06% is ovicidal for strongyle eggs.
For the treatment of cattle and sheep infested with benzimidazole
susceptible strains of the following species:
GASTRO-INTESTINAL ROUNDWORMS:
_Ostertagia_ spp., _Haemonchus_ spp., _Nematodirus_ spp., including
N_. battus_, _Trichostrongylus _spp., _Cooperia_ spp., _Bunostomum_
spp., _Oesophagostomum_ spp., _Chabertia_ spp., _Capillaria_ spp.,
_Trichuris_ spp..
LUNGWORMS: _Dictyocaulu_s spp.
TAPEWORMS: _Moniezia_ spp.
In cattle it is also effective against inhibited larvae of _Cooperia_
spp. and usually effective against inhibited/arrested larvae of
_Ostertagia_ spp.. In sheep it is effective against inhibited/arrested
larvae of _Nematodirus_ spp., and benzimidazole susceptible
_Haemonchus_ spp. and _Ostertagia_ spp..
4.3 CONTRAINDICATIONS
Parafend 9.06% is contra-indicated in animals with known
hypersensitivity to the active ingredient. Do not use in sheep
producing milk for human consumption.
Health Products Regulatory Authority
27 February 2019
CRN008WGG
Page 2 of 4
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
As with other anthelmintics, veterinary advice should be sought on
appropriate dosing programmes and stock management to
achieve adequate parasite control and reduce the likelihood of
anthelmintic resistance developing. If